Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel

Human biglycan is a small proteoglycan that is expressed at high levels in the growing skeleton and in human skin at the cell surface of differentiating keratinocytes. The human gene for biglycan (BGN) has previously been mapped by in situ hybridization to the Xq27–q28 region. Employing somatic hybr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Genomics (San Diego, Calif.) Calif.), 1992-06, Vol.13 (2), p.481-483
Hauptverfasser: Traupe, Heiko, van den Ouweland, Ans M.W., van Oost, Bernard A., Vogel, Walther, Vetter, Ulrich, Warren, Stephen T., Rocchi, Mariano, Darlison, Mark G., Ropers, Hans-Hilger
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Human biglycan is a small proteoglycan that is expressed at high levels in the growing skeleton and in human skin at the cell surface of differentiating keratinocytes. The human gene for biglycan (BGN) has previously been mapped by in situ hybridization to the Xq27–q28 region. Employing somatic hybrid cell lines with human X chromosome breakpoints within this region, we performed a fine mapping of the gene within Xq28. Our results indicate that the biglycan gene is proximal to the red/green cone pigment genes, G6PD, and coagulation factor VIII and is distal to DXS304, DXS305, and GABRA3. The biglycan gene precisely maps to a region of the X chromosome, where, by comparative gene mapping, one would expect to find the gene for X-linked dominant chondrodysplasia punctata/ichthyosis/short stature (Happle) syndrome. Hence, BGN is a candidate gene for the Happle syndrome.
ISSN:0888-7543
1089-8646
DOI:10.1016/0888-7543(92)90279-2